High Prevalence of strongyloidiasis in Spain: a hospital-based study
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Requena-Méndez, Ana
- dc.contributor.author Salas-Coronas, Joaquín
- dc.contributor.author Salvador, Fernando
- dc.contributor.author Gomez-Junyent, Joan
- dc.contributor.author Villar García, Judit
- dc.contributor.author Santín, Miguel
- dc.contributor.author Muñoz, Carme
- dc.contributor.author González-Cordón, Ana
- dc.contributor.author Cabezas Fernández, Maria Teresa
- dc.contributor.author Sulleiro, Elena
- dc.contributor.author Arenas-Miras, María Del Mar
- dc.contributor.author Somoza, Dolors
- dc.contributor.author Vazquez-Villegas, Jose
- dc.contributor.author Treviño, Begoña
- dc.contributor.author Rodríguez, Esperanza
- dc.contributor.author Valls, Maria Eugenia
- dc.contributor.author Llaberia-Marcual, Jaume
- dc.contributor.author Subirá, Carme
- dc.contributor.author Muñoz, José
- dc.date.accessioned 2021-04-26T07:30:36Z
- dc.date.available 2021-04-26T07:30:36Z
- dc.date.issued 2020
- dc.description.abstract Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI -0.3-6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
- dc.format.mimetype application/pdf
- dc.identifier.citation Requena-Méndez A, Salas-Coronas J, Salvador F, Gomez-Junyent J, Villar-Garcia J, Santin M, et al. High Prevalence of strongyloidiasis in Spain: a hospital-based study. Pathogens. 2020 Feb 11; 9(2): 107. DOI: 10.3390/pathogens9020107
- dc.identifier.doi http://dx.doi.org/10.3390/pathogens9020107
- dc.identifier.issn 2076-0817
- dc.identifier.uri http://hdl.handle.net/10230/47194
- dc.language.iso eng
- dc.publisher MDPI
- dc.rights Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Spain
- dc.subject.keyword Strongyloides stercoralis
- dc.subject.keyword Migrants
- dc.subject.keyword Prevalence
- dc.subject.keyword Strongyloidiasis
- dc.title High Prevalence of strongyloidiasis in Spain: a hospital-based study
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion